F. Bevilacqua

Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.

N. Davis-Poynter, G. Darby, P. Collins, 1995, The Journal of general virology.

A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.

G. Gerna, G. Palù, A. Marcello, 1992, Virus research.

Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.

G. Palù, M. Tognon, M. Romanelli, 1989, Virus research.

pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus.

J. Prolla, S. Contu, L. F. Moreira, 2007, World journal of gastroenterology.

Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.

G. Gerna, M. Zavattoni, G. Palù, 1991, Journal of acquired immune deficiency syndromes.

Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection.

G. Palù, A. Vaona, G. Pisoni, 1995, Journal of virological methods.

Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents.

G. Palù, G. Cristalli, S. Vittori, 1995, Journal of medicinal chemistry.